Amplia Therapeutics Limited


Amplia Therapeutics Limited is based in Melbourne, Australia. It is engaged with the development of FAK (Focal Adhesion Kinase) for the treatment of diseases like cancer and fibrosis. FAK is positioning itself as a significant pick in the cancer immunology and Amplia. Some of the company’s drug candidate include- AMP945 & AMP886.

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK